Clinical Trials
10 trialsNCT05490719 2024-05-21
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05448820 2023-09-21
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Tracon Pharmaceuticals Inc.
Phase 1/2 Unknown
NCT05990231 2023-09-11
Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
NCT05915481 2023-06-23
SCARCE
Peking University Third Hospital
Phase 1/2 Unknown
NCT04631731 2023-06-01
ICEMELT
Western Sydney Local Health District
Phase 1/2 Unknown
NCT05235438 2023-05-24
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Unknown
NCT03356782 2020-06-11
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT03182803 2017-06-09
CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor
Shanghai Cell Therapy Research Institute
Phase 1/2 Unknown
NCT03182816 2017-06-09
CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor
Shanghai Cell Therapy Research Institute
Phase 1/2 Unknown
NCT03179007 2017-06-07
CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor
Shanghai Cell Therapy Research Institute
Phase 1/2 Unknown